The UAE Cabinet has officially adopted a national policy for the integration of Artificial Intelligence within the healthcare sector. This policy aims to guide the deployment and regulation of AI technologies to improve healthcare services and outcomes across the Emirates. It is expected to address aspects like data privacy, ethical considerations, and operational frameworks for AI applications in medical diagnosis, treatment, and administration. Why it matters: This policy signifies a strategic move by the UAE to standardize and accelerate AI adoption in a critical sector, potentially positioning it as a leader in AI-driven healthcare in the Middle East.
Bahrain's sovereign wealth fund Mumtalakat has partnered with SandboxAQ to enhance Bahrain's biotechnology sector. SandboxAQ will establish its regional headquarters in Bahrain, focusing on developing quantum AI talent and infrastructure in areas like AI, quantum computing, and cybersecurity. This collaboration aims to accelerate innovation in critical sectors such as healthcare, materials science, and clean energy. Why it matters: This strategic partnership positions Bahrain as a regional hub for advanced quantum AI applications, driving economic diversification and human capital development in high-tech industries.
Technology Innovation Institute (TII) won the UAE AI Award for Emirati AI Solutions for its Falcon LLM series. AI71 also won for LAW71, an AI-powered legal solution, and RAZI71, an AI-powered healthcare solution. The award recognizes AI innovations made in the UAE that demonstrate innovation, AI ethics compliance, maturity, and scalability. Why it matters: The award highlights the UAE's commitment to developing local AI talent and solutions, particularly in open-source models, for global collaboration and positive transformation.
Abu Dhabi’s Advanced Technology Research Council (ATRC) launched the ‘ATRC Global Tech R&D Platform’ at the World Governments Summit (WGS) 2024. The platform aims to provide countries access to the UAE's technological expertise and address their unique challenges. ATRC is allocating US$200 million in funding to accelerate innovation for emerging and developing nations, focusing on sectors like aerospace, healthcare, and sustainability. Why it matters: This initiative positions the UAE as a global hub for technology R&D and strengthens its role in fostering inclusive growth by providing crucial support to developing nations.
KAUST has unveiled Shaheen III, the most powerful supercomputer in the Middle East and 18th globally, built by HPE. The system uses 2,800 NVIDIA GH200 Grace Hopper Superchips, tripling the processing power of its predecessor. Shaheen III will support research in Arabic LLMs, climate modeling, remote sensing, automated chemistry, and AI-driven healthcare. Why it matters: This infrastructure investment strengthens Saudi Arabia's position in AI and computational research, enabling advances tailored to the region's needs and priorities.
Scientists at King Abdullah University of Science and Technology (KAUST) have developed a new stain-free imaging platform using engineered silicon slides to analyze tissue samples, aiming for quicker and more consistent cancer diagnostics. This platform removes the need for conventional chemical staining, reducing preparation time by approximately 40-50% and improving consistency. In validation tests with 120 colorectal tissue samples, the technology achieved a 99% agreement rate with traditional pathology assessments. Why it matters: This innovation could significantly streamline cancer diagnosis workflows, reduce variability, and generate standardized data crucial for the advancement of AI-assisted diagnostic tools in healthcare.
M42, a UAE-based healthcare company, has launched an AI-powered tool specifically designed for prostate cancer diagnosis. The technology aims to enhance the accuracy and efficiency of detecting prostate cancer, potentially improving patient outcomes through earlier intervention. This diagnostic solution represents a step forward in integrating artificial intelligence into clinical practice within the region. Why it matters: This development signifies a notable advancement in the application of AI in healthcare in the UAE, potentially positioning the country as a leader in medical AI innovation and improving public health.
M42 is introducing AI-driven diagnostic tools for prostate cancer in the UAE. This initiative aims to enhance the early detection and diagnosis of prostate cancer within the region's healthcare system. The technology leverages artificial intelligence to improve the accuracy and efficiency of diagnostic processes. Why it matters: This development marks a significant advancement in the application of AI within the Middle East's healthcare sector, potentially leading to improved patient outcomes and fostering the adoption of cutting-edge medical technologies in the UAE.